Janux Therapeutics, Inc. - Common Stock - Bilanço (NASDAQ:JANX) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Toplam varlıklar 379.82 M364.01 M380.41 M1.06 B1 B Toplam yükümlülükler 13.5 M43.27 M36.06 M38.73 M44.74 M Toplam özsermaye 366.33 M320.74 M344.35 M1.02 B956.82 M Toplam yükümlülükler ve hissedarların özsermayesi 379.82 M364.01 M380.41 M1.06 B1 B Toplam borç ————— Net borç —————

Haberler

Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know

Here's Why You Should Add JANX Stock to Your Portfolio Now

Janux Therapeutics başkan yardımcısı 28.878 dolarlık hisse sattı

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%

Undercovered Stocks: Western Digital, SAP, Toast And More

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value (JANX)

BofA, Janux Therapeutics’in hedef fiyatını düşürdü

Janux kanser tedavisi geliştirme programını sonlandırdı

Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects (NYSE:BMY)

H.C. Wainwright, Janux Therapeutics için al tavsiyesini yineledi

Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs?